Pear Therapeutics announced on Wednesday that the Massachusetts Medicaid program plans to cover its digital prescriptions for treating substance and opioid disorders, reboots and reboots.
The decision to cover digital therapies under MassHealth is subject to federal and state approval, as well as the availability of funding.
“We applaud MassHealth for their leadership in implementing PDT among the Medicaid population to provide safe and effective treatment options for patients who have been cured,” the Pear president and CEO said in a statement.
“Pear proudly helps fight drug addiction in Massachusetts, especially at a time when the COVID-19 pandemic is exacerbating the drug addiction crisis in America with national deaths from drug overdoses will increase by almost 30% in 2020. ”
Why it matters
There is a large market for digital therapy if they can get compensation through government payers.
More than 80 million people in the United States receive health insurance through Medicaid or the Child Health Insurance Program (CHIP). in line with admission trends at the Medicaid Health Services and Services Center released in June. Nearly 9.9 million people were enrolled between February 2020 and January 2021.
Dr. Andrei Ostrovsky, managing partner of Social Innovation Partners and former chief physician of the U.S. Medicaid program, said clinical trial data and outcomes are key to getting involved in Medicaid programs.
“The first line, if you don’t take anything away from it, if you’re trying to sell in Medicaid, is to have Medicaid [beneficiaries] in your sample when you conduct research. It’s nice to have real data, but you need randomized trials. ” Ostrovsky told about it last month at DTx East in Boston.
Other countries have taken steps to reimburse the cost of digital therapy. In 2019, Germany passed a regulation that allows doctors to prescribe medical applications to patients and receive money through the country’s statutory insurance.
“At the German Ministry of Health, we have a very broad approach to the digital formation of health care,” said Jan Hensmann, head of the e-intelligence unit of the German Ministry of Health. during a panel discussion in February.
“We have really touched on this topic in different areas over the last three or four years. Let me say this. I think that with the digitalisation of healthcare you have to take a common perspective. Everything has to come together. – it’s the industry, it’s the healthcare, it’s the professionals, it’s the patients. “
Meanwhile the government of Scotland announced today that adult residents will have access to digital daylight treatments and Sleepio for health care from anxiety and insomnia through the National Health Service.
“The COVID-19 pandemic only confirmed what we knew from the beginning – Digital mental health is crucial to help expand the services available and give people more choice to manage their mental health, ”Scotland’s Minister of Mental Welfare and Social Welfare Kevin Stewart said in a statement.
“After evaluating the effectiveness of Daylight and Sleepio, we are excited to launch these procedures nationwide, providing clinically sound solutions for those who need it most.”
The pear held several research for measurement impact and economic efficiency reboot. A study published last month found that “replenishment” of digital therapy was associated with high levels of opioid abstinence and treatment content, as well as fewer hospital appointments.
Another studies since August found that together with reSET-O counseling and buprenarphine counseling they reduced the cost of treating opioid disorders compared to traditional treatment alone.
Pear recently raised a total of $ 100 million to fund the D Series to be able to recoup the cost of their products.
In June Pear announced plans to go public through a special purpose company (SPAC) merger of $ 1.6 billion.